|
CCDC85C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87939680379645E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24376073276744E-12 |
| Normal-vs-Stage2 |
1.2521000014587E-08 |
| Normal-vs-Stage3 |
7.73450000046694E-07 |
| Normal-vs-Stage4 |
4.2621000000409E-06 |
| Stage1-vs-Stage2 |
2.616200E-01 |
| Stage1-vs-Stage3 |
7.015200E-01 |
| Stage1-vs-Stage4 |
3.464800E-01 |
| Stage2-vs-Stage3 |
2.232000E-01 |
| Stage2-vs-Stage4 |
9.065600E-01 |
| Stage3-vs-Stage4 |
3.052000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.4035996243631E-10 |
| Normal-vs-AfricanAmerican |
1.50559564815467E-11 |
| Normal-vs-Asian |
1.8539999535605E-09 |
| Caucasian-vs-AfricanAmerican |
8.583200E-01 |
| Caucasian-vs-Asian |
4.477500E-03 |
| AfricanAmerican-vs-Asian |
7.283700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07740047386551E-10 |
| Normal-vs-Female |
1.97729999040774E-09 |
| Male-vs-Female |
8.245200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.94410043619087E-11 |
| Normal-vs-Extreme_Weight |
4.35160000256118E-08 |
| Normal-vs-Obese |
1.7168999999484E-08 |
| Normal-vs-Extreme_Obese |
1.65144999999534E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.406600E-01 |
| Normal_Weight-vs-Obese |
4.920200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.130800E-01 |
| Extreme_Weight-vs-Obese |
5.623600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.784400E-01 |
| Obese-vs-Extreme_Obese |
3.428600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.169650E-04 |
| Normal-vs-Age(41-60Yrs) |
1.17399978627475E-10 |
| Normal-vs-Age(61-80Yrs) |
7.97520049999889E-10 |
| Normal-vs-Age(81-100Yrs) |
1.51967999999503E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.509000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.180800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.976400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.993440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.751600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.464800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62547753035369E-12 |
| Normal-VS-Type2 PRCC |
2.14460005310002E-10 |
| Normal-VS-KIRP CIMP |
9.942600E-03 |
| Normal-VS-Unclassified PRCC |
5.73980000195817E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.614000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.881900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.164400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.220630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.496000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.718400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61709542925814E-11 |
| Normal-vs-N1 |
1.806970E-04 |
| Normal-vs-N2 |
3.986600E-04 |
| N0-vs-N1 |
1.660170E-03 |
| N0-vs-N2 |
3.890400E-01 |
| N1-vs-N2 |
5.516400E-02 |
|
|
